1 / 16

Viral Vector Manufacturing Market

The increasing interest in the R&D in novel cell and gene therapies, along with the need for efficient platforms for drug discovery and vaccine discovery, is expected to fuel the marketu2019s growth during the forecast period. The growing importance of stem cell technology and the emergence of the COVID-19 pandemic will provide an opportunity for the production market to grow in the coming years.

Ronald15
Télécharger la présentation

Viral Vector Manufacturing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Viral Vector Manufacturing Market Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6%

  2. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% “As per Polaris Market Research report, Viral Vector Manufacturing Market is attending major innovations & transformations and is projected to reach $3.70 Billion By 2028 | CAGR: 18.6% during the conjecture period 2021 to 2028.” The global Viral Vector Manufacturing Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Viral Vector Manufacturing Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Viral Vector Manufacturing Market Report Scope: The global Viral Vector Manufacturing Market is segmented By Vector, By Workflow, By Application, By End- use, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Viral Vector Manufacturing Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Viral Vector Manufacturing Market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% By Vector By Workflow By Application By End-use By Region • • • • • • • Adenovirus Retrovirus Adeno- Associated Virus (AAV) Lentivirus Others Upstream Processing o Vector Amplification and Expansion o Vector Recovery/Harvestin g Downstream Processing o Purification Fill Finish Gene and Cell Therapy Development Vaccine Development Biopharmaceutical & Pharmaceutical Discovery Biomedical Research Pharmaceutical & Biopharmaceutic al Companies Research Institutes North America (U.S., Canada) Europe (Austria, France, Germany, Italy, Netherlands, Spain, UK) Asia Pacific (China, India, Indonesia, Japan, Malaysia, South Korea) Latin America (Argentina, Brazil, Mexico) Middle East & Africa (Israel, Saudi Arabia, South Africa, UAE) • • • • • • • • • • • • ➢COVID-19 Impact Analysis for Viral Vector Manufacturing Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Viral Vector Manufacturing Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Viral Vector Manufacturing Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Viral Vector Manufacturing Market Analysis: https://www.polarismarketresearch.com/industry-analysis/viral-vector-manufacturing-market - 3 -

  4. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Viral Vector Manufacturing Market include Addgene, Inc., Advanced BioScience Laboratories, Inc. (ABL, Inc.), Aldevron, L.L.C., Audentes Therapeutics, Batavia Biosciences B.V., BioMarin Pharmaceutical, BioNTech IMFS GmbH, Biovion oy, BlueBird Bio, Catalent Inc., Cell and Gene Therapy Catapult, CEVEC Pharmaceuticals GmbH, Cobra Biologics Ltd., Creative Biogene, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., General Electric Company (GE Healthcare), Genezen, Lonza, Merck KGaA, Miltenyi Biotec GmbH, Novasep Holding S.A.S, Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.), RegenxBio, Inc., SIRION Biotech GmbH, Takara Bio., Thermo Fisher Scientific, VGXI, Inc., Vibalogics GmbH, Vigene Biosciences, Inc., Virovek Incorporation, VIVEbiotech S.L., Waisman Biomanufacturing, Wuxi AppTec Co., Ltd., YPOSKESI. Request for sample: https://www.polarismarketresearch.com/industry-analysis/viral-vector- manufacturing-market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Products 3.2.1.Primary Products 3.2.2.Secondary Products 4.Viral Vector Manufacturing Market Insights 4.1.Viral Vector Manufacturing – Industry snapshot 4.2.Viral Vector Manufacturing Market Dynamics - 4 -

  5. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 4.2.1.Drivers and Opportunities 4.2.1.1. Increase in research activities 4.2.1.2. The recent surge in infectious diseases 4.2.2.Restraints and Challenges 4.2.2.1. Limited use 4.2.3.Porter’s Five Forces Analysis 4.2.3.1. Bargaining Power of Suppliers (Moderate) 4.2.3.2. Threats of New Entrants: (Low) 4.2.3.3. Bargaining Power of Buyers (Moderate) 4.2.3.4. Threat of Substitute (Moderate) 4.2.3.5. Rivalry among existing firms (High) 4.2.4.PESTLE Analysis 4.2.5.Viral Vector Manufacturing Market Industry trends 4.2.6.COVID-19 Impact Anlaysis 5.Viral Vector Manufacturing Market Assessment by Vecto 5.1.Key Findings 5.2.Introduction 5.2.1.Global Viral Vector Manufacturing Market, by Vector, 2016 – 2028 (USD Million) 5.3.Adenovirus 5.3.1.Global Adenovirus Market, by Region, 2016- 2028 (USD Million) 5.4.Retrovirus 5.4.1.Global Retrovirus Market, by Region, 2016- 2028 (USD Million) 5.5.Adeno-Associated Virus (AAV) 5.5.1.Global Adeno-Associated Virus (AAV) Market, by Region, 2016- 2028 (USD Million) 5.6.Lentivirus 5.6.1.Global Lentivirus Market, by Region, 2016- 2028 (USD Million) 5.7.Others 5.7.1.Global Other Vectors Market, by Region, 2016- 2028 (USD Million) 6.Viral Vector Manufacturing Market Assessment by Workflow 6.1.Key Findings 6.2.Introduction 6.2.1.Global Viral Vector Manufacturing Market, by Workflow, 2016 – 2028 (USD Million) 6.3.Upstream Processing 6.3.1.Global Upstream Processing Market, by Region, 2016- 2028 (USD Million) 6.3.2.Vector Amplification and Expansion 6.3.2.1. Global Vector Amplification and Expansion Market, by Region, 2016- 2028 (USD Million) 6.3.3.Vector Recovery/Harvesting 6.3.3.1. Global Vector Recovery/Harvesting Market, by Region, 2016- 2028 (USD Million) 6.4.Downstream Processing 6.4.1.Global Downstream Processing Market, by Region, 2016- 2028 (USD Million) 6.4.2.Purification 6.4.2.1. Global Purification Market, by Region, 2016- 2028 (USD Million) 6.4.3.Fill Finish - 5 -

  6. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 6.4.3.1. Global Fill Finish Market, by Region, 2016- 2028 (USD Million) 7.Global Viral Vector Manufacturing Market, by Application 7.1.Key Findings Introduction 7.1.1.Global Viral Vector Manufacturing Market, by Application, 2016 – 2028 (USD Million) 7.2.Gene and Cell Therapy Development 7.2.1.Global Gene and Cell Therapy Development Application Market, By Region, 2016- 2028 (USD Million) 7.3.Vaccine Development 7.3.1.Global Vaccine Development Application Market, By Region, 2016- 2028 (USD Million) 7.4.Biopharmaceutical & Pharmaceutical Discovery 7.4.1.Global Biopharmaceutical & Pharmaceutical Discovery Application Market, By Region, 2016- 2028 (USD Million) 7.5.Biomedical Research 7.5.1.Global Biomedical Research Application Market, By Region, 2016- 2028 (USD Million) 8.Global Viral Vector Manufacturing Market, by End-use 8.1.Key Findings 8.2.Introduction 8.2.1.Global Viral Vector Manufacturing Market, by End-use, 2016 – 2028 (USD Million) 8.3.Pharmaceutical & Biopharmaceutical Companies 8.3.1.Global Viral Vector Manufacturing Market, By Pharmaceutical & Biopharmaceutical Companies end-use, By Region, 2016- 2028 (USD Million) 8.4.Research Institutes 8.4.1.Global Viral Vector Manufacturing Market, by Research Institutes end-use, by Region, 2016- 2028 (USD Million) 9.Viral Vector Manufacturing Market Assessment by Geography 9.1.Key findings 9.2.Introduction 9.2.1.Viral Vector Manufacturing Market Assessment, By Geography, 2016- 2028 (USD Million) 9.3.Viral Vector Manufacturing Market – North America 9.3.1.North America: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) - 6 -

  7. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.3.2.North America: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.3.3.North America: Viral Vector Manufacturing Market, by Application, 2016 - 2028 (USD Million) 9.3.4.North America: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.3.5.Viral Vector Manufacturing Market – U.S. 9.3.5.1. U.S.: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.3.5.2. U.S.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.3.5.3. U.S.: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.3.5.4. U.S.: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.3.6.Viral Vector Manufacturing Market – Canada 9.3.6.1. Canada: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.3.6.2. Canada.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.3.6.3. Canada: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.3.6.4. Canada: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.Viral Vector Manufacturing Market – Europe 9.4.1.Europe: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.2.Europe.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.3.Europe: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.4.Europe: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.5.Viral Vector Manufacturing Market – UK 9.4.5.1. UK: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.5.2. UK.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.5.3. UK: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.5.4. UK: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.6.Viral Vector Manufacturing Market – France 9.4.6.1. France: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.6.2. France.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) - 7 -

  8. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.4.6.3. France: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.6.4. France: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.7.Viral Vector Manufacturing Market – Germany 9.4.7.1. Germany: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.7.2. Germany.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.7.3. Germany: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.7.4. Germany: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.8.Viral Vector Manufacturing Market – Italy 9.4.8.1. Italy: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.8.2. Italy.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.8.3. Italy: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.8.4. Italy: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.9.Viral Vector Manufacturing Market – Spain 9.4.9.1. Spain: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.9.2. Spain.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.9.3. Spain: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.9.4. Spain: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.10.Viral Vector Manufacturing Market – Netherlands 9.4.10.1.Netherlands: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.10.2.Netherlands.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.4.10.3.Netherlands: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.10.4.Netherlands: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.4.11.Viral Vector Manufacturing Market – Austria 9.4.11.1.Austria: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.4.11.2.Austria.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) - 8 -

  9. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.4.11.3.Austria: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.4.11.4.Austria: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.Viral Vector Manufacturing Market – Asia-Pacific 9.5.1.Asia Pacific: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.2.Asia Pacific.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.3.Asia-pacific: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.4.Asia-pacific: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.5.Viral Vector Manufacturing Market – China 9.5.5.1. China: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.5.2. China.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.5.3. China: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.5.4. China: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.6.Viral Vector Manufacturing Market – India 9.5.6.1. India: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.6.2. India.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.6.3. India: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.6.4. India: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.7.Viral Vector Manufacturing Market – Malaysia 9.5.7.1. Malaysia: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.7.2. Malaysia.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.7.3. Malaysia: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.7.4. Malaysia: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.8.Viral Vector Manufacturing Market – Japan 9.5.8.1. Japan: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.8.2. Japan.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) - 9 -

  10. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.5.8.3. Japan: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.8.4. Japan: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.9.Viral Vector Manufacturing Market – Indonesia 9.5.9.1. Indonesia: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.9.2. Indonesia.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.9.3. Indonesia: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.9.4. Indonesia: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.5.10.Viral Vector Manufacturing Market – South Korea 9.5.10.1.South Korea: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.5.10.2.South Korea.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.5.10.3.South Korea: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.5.10.4.South Korea: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.6.Viral Vector Manufacturing Market – Middle East & Africa 9.6.1.Middle East & Africa: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.6.2.Middle East & Africa.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.6.3.Middle East & Africa: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.6.4.Middle East & Africa: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.6.5.Viral Vector Manufacturing Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.6.5.2. Saudi Arabia.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.6.5.3. Saudi Arabia: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.6.5.4. Saudi Arabia: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.6.6.Viral Vector Manufacturing Market – UAE 9.6.6.1. UAE: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.6.6.2. UAE.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) - 10 -

  11. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.6.6.3. UAE: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.6.6.4. UAE: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.6.7.Viral Vector Manufacturing Market – Israel 9.6.7.1. Israel: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.6.7.2. Israel.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.6.7.3. Israel: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.6.7.4. Israel: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.6.8.Viral Vector Manufacturing Market – South Africa 9.6.8.1. South Africa: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.6.8.2. South Africa.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.6.8.3. South Africa: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.6.8.4. South Africa: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.7.Viral Vector Manufacturing Market – Latin America 9.7.1.Latin America: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.7.2.Latin America.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.7.3.Latin America: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.7.4.Latin America: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.7.5.Viral Vector Manufacturing Market – Mexico 9.7.5.1. Mexico: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.7.5.2. Mexico.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.7.5.3. Mexico: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.7.5.4. Mexico: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.7.6.Viral Vector Manufacturing Market – Brazil 9.7.6.1. Brazil: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.7.6.2. Brazil.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) - 11 -

  12. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 9.7.6.3. Brazil: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.7.6.4. Brazil: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 9.7.7.Viral Vector Manufacturing Market – Argentina 9.7.7.1. Argentina: Viral Vector Manufacturing Market, by Vector, 2016- 2028 (USD Million) 9.7.7.2. Argentina.: Viral Vector Manufacturing Market, by End-use, 2016- 2028 (USD Million) 9.7.7.3. Argentina: Viral Vector Manufacturing Market, by Application, 2016- 2028 (USD Million) 9.7.7.4. Argentina: Viral Vector Manufacturing Market, by Workflow, 2016- 2028 (USD Million) 10.Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1.Expansion 10.1.2.Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11.Company Profiles 11.1. Addgene, Inc. 11.1.1.Company Overview 11.1.2.Financial Performance 11.1.3.Product Benchmarking 11.1.4.Recent Development 11.2. Advanced BioScience Laboratories, Inc. (ABL, Inc.) 11.2.1.Company Overview 11.2.2.Financial Performance 11.2.3.Product Benchmarking 11.2.4.Recent Development 11.3. Aldevron, L.L.C. 11.3.1.Company Overview 11.3.2.Financial Performance 11.3.3.Product Benchmarking 11.3.4.Recent Development 11.4. Audentes Therapeutics 11.4.1.Company Overview 11.4.2.Financial Performance 11.4.3.Product Benchmarking 11.4.4.Recent Development 11.5. Batavia Biosciences B.V. 11.5.1.Company Overview 11.5.2.Financial Performance - 12 -

  13. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 11.5.3.Product Benchmarking 11.5.4.Recent Development 11.6. BioMarin Pharmaceutical 11.6.1.Company Overview 11.6.2.Financial Performance 11.6.3.Product Benchmarking 11.6.4.Recent Development 11.7. BioNTech IMFS GmbH 11.7.1.Company Overview 11.7.2.Financial Performance 11.7.3.Product Benchmarking 11.7.4.Recent Development 11.8. Biovion oy 11.8.1.Company Overview 11.8.2.Financial Performance 11.8.3.Product Benchmarking 11.8.4.Recent Development 11.9. BlueBird Bio 11.9.1.Company Overview 11.9.2.Financial Performance 11.9.3.Product Benchmarking 11.9.4.Recent Development 11.10. Catalent Inc. 11.10.1. Company Overview 11.10.2. Financial Performance 11.10.3. Product Benchmarking 11.10.4. Recent Development 11.11. Cell and Gene Therapy Catapult 11.11.1. Company Overview 11.11.2. Financial Performance 11.11.3. Product Benchmarking 11.11.4. Recent Development 11.12. CEVEC Pharmaceuticals GmbH 11.12.1. Company Overview 11.12.2. Financial Performance 11.12.3. Product Benchmarking 11.12.4. Recent Development 11.13. Cobra Biologics Ltd. 11.13.1. Company Overview 11.13.2. Financial Performance 11.13.3. Product Benchmarking 11.13.4. Recent Development - 13 -

  14. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 11.14. Creative Biogene 11.14.1. 11.14.2. 11.14.3. 11.14.4. 11.15. 11.15.1. 11.15.2. 11.15.3. 11.15.4. 11.16. 11.16.1. 11.16.2. 11.16.3. 11.16.4. 11.17. 11.17.1. 11.17.2. 11.17.3. 11.17.4. 11.18. 11.18.1. 11.18.2. 11.18.3. 11.18.4. 11.19. 11.19.1. 11.19.2. 11.19.3. 11.19.4. 11.20. 11.20.1. 11.20.2. 11.20.3. 11.20.4. 11.21. 11.21.1. 11.21.2. 11.21.3. 11.21.4. 11.22. Company Overview Financial Performance Product Benchmarking Recent Development FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Overview Financial Performance Product Benchmarking Recent Development General Electric Company (GE Healthcare) Company Overview Financial Performance Product Benchmarking Recent Development Genezen Company Overview Financial Performance Product Benchmarking Recent Development Lonza Company Overview Financial Performance Product Benchmarking Recent Development Merck KGaA Company Overview Financial Performance Product Benchmarking Recent Development Miltenyi Biotec GmbH Company Overview Financial Performance Product Benchmarking Recent Development Novasep Holding S.A.S Company Overview Financial Performance Product Benchmarking Recent Development Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) - 14 -

  15. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 11.22.1. 11.22.2. 11.22.3. 11.22.4. 11.23. 11.23.1. 11.23.2. 11.23.3. 11.23.4. 11.24. 11.24.1. 11.24.2. 11.24.3. 11.24.4. 11.25. 11.25.1. 11.25.2. 11.25.3. 11.25.4. 11.26. 11.26.1. 11.26.2. 11.26.3. 11.26.4. 11.27. 11.27.1. 11.27.2. 11.27.3. 11.27.4. 11.28. 11.28.1. 11.28.2. 11.28.3. 11.28.4. 11.29. 11.29.1. 11.29.2. 11.29.3. 11.29.4. 11.30. 11.30.1. 11.30.2. Company Overview Financial Performance Product Benchmarking Recent Development RegenxBio, Inc. Company Overview Financial Performance Product Benchmarking Recent Development SIRION Biotech GmbH Company Overview Financial Performance Product Benchmarking Recent Development Takara Bio. Company Overview Financial Performance Product Benchmarking Recent Development Thermo Fisher Scientific Company Overview Financial Performance Product Benchmarking Recent Development VGXI, Inc. Company Overview Financial Performance Product Benchmarking Recent Development Vibalogics GmbH Company Overview Financial Performance Product Benchmarking Recent Development Vigene Biosciences, Inc. Company Overview Financial Performance Product Benchmarking Recent Development Virovek Incorporation Company Overview Financial Performance - 15 -

  16. Viral Vector Manufacturing Market Size Worth $3.70 Billion By 2028 | CAGR: 18.6% 11.30.3. 11.30.4. 11.31. 11.31.1. 11.31.2. 11.31.3. 11.31.4. 11.32. 11.32.1. 11.32.2. 11.32.3. 11.32.4. 11.33. 11.33.1. 11.33.2. 11.33.3. 11.33.4. 11.34. 11.34.1. 11.34.2. 11.34.3. 11.34.4. Product Benchmarking Recent Development VIVEbiotech S.L. Company Overview Financial Performance Product Benchmarking Recent Development Waisman Biomanufacturing Company Overview Financial Performance Product Benchmarking Recent Development Wuxi AppTec Co., Ltd. Company Overview Financial Performance Product Benchmarking Recent Development YPOSKESI Company Overview Financial Performance Product Benchmarking Recent Development ➢Access Press Release on Viral Vector Manufacturing Market: https://www.polarismarketresearch.com/press-releases/viral-vector-manufacturing-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com - 16 - Official Blog: http://polarismarketresearch.blogspot.com

More Related